SCHEMBL4057197

SCHEMBL4057197

Cc1ccc2c(c1)NS(=O)(=O)N2c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.40
KDM4E B2RXH2 5/20 0.40
HSD17B10 Q99714 4/20 0.40
PTPN1 P18031 1/20 0.35
PTPN7 P35236 1/20 0.34
PDE5A O76074 1/20 0.34
CYP1A2 P05177 2/20 0.33
HPGD P15428 2/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA4 P22748 1/20 0.33
CA7 P43166 1/20 0.33
CA9 Q16790 1/20 0.33
BLM P54132 1/20 0.33
MAPT P10636 3/20 0.33
FGFR1 P11362 1/20 0.33
CSNK1G1 Q9HCP0 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4065236 0.81 ALDH1A1 (0.37) ALDH1A1PTPN1CA12CA1CA2
SCHEMBL4063463 0.81 SLC6A2 (0.39) ALDH1A1PTPN1CA12CA1CA2
SCHEMBL4055064 0.81 LMNA (0.39) ALDH1A1KDM4EHPGDMAPTNPC1
SCHEMBL4059648 0.80 SLC6A2 (0.42) ALDH1A1HSD17B10HPGDMAPTMEN1
SCHEMBL3596885 0.80 PTPN1 (0.41) KDM4EPTPN1CA12CA1CA2
SCHEMBL3600016 0.75 KDM4E (0.35) ALDH1A1KDM4EHSD17B10CA12CA1
SCHEMBL4056951 0.72 CHRM1 (0.39) ALDH1A1KDM4EPTPN1HPGDCA12
SCHEMBL4064417 0.72 CA12 (0.37) ALDH1A1PTPN1CA12CA1CA2
SCHEMBL3606142 0.69 SLC6A2 (0.44) ALDH1A1KDM4ECYP1A2MAPTFGFR1
SCHEMBL29638503 0.68 ALDH1A1 (0.53) ALDH1A1KDM4EHSD17B10CYP1A2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2061776-A1 ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE Wyeth a Corporation of the State of Delaware (US) 2009-05-27 EP disclosed
US-20080161366-A1 AMINOALKYL SUBSTITUTED ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE WYETH (US) 2008-07-03 US disclosed
WO-2008073459-A1 ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE WYETH (US) 2008-06-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161366-A1 AMINOALKYL SUBSTITUTED ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE SLC6A4, SLC6A2, SLC6A3 ALDH1A1 687/4885KDM4E 3015/4885HSD17B10 719/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.